Bladder Cancer - Results from #180

Evaluation of the Cancer of Bladder Risk Assessment (COBRA) Score in the Cancer Genome Atlas (TCGA) Bladder Cancer Cohort. June 14, 2021

Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex. June 11, 2021

Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. June 11, 2021

Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions. June 10, 2021

Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer. June 10, 2021

Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study. June 9, 2021

Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG. June 9, 2021

Efficacy and toxicity of intravesical Bacillus Calmette-Guérin therapy in elderly patients with non-muscle-invasive bladder cancer. June 8, 2021

Comparison of the clinical usefulness of different urinary tests for the initial detection of bladder cancer: a systematic review. June 8, 2021

Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol. June 7, 2021

Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma. June 7, 2021

A Rare Variant in ERF (rs144812092) Predisposes to Prostate and Bladder Cancers in an Extended Pedigree. June 4, 2021

Immune Checkpoint Inhibition in Advanced Bladder and Kidney Cancer: Responses and Further Management. June 4, 2021

Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer. June 3, 2021

Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer. June 3, 2021

Association of smoking status and recurrence of non-muscle invasive bladder cancer among patients managed with blue light cystoscopy. June 2, 2021

Evaluation of Bowel Function Following Radical Cystectomy and Urinary Diversion Using Two Validated Questionnaires: What Are the Effects on Quality of Life? June 2, 2021

Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy. June 1, 2021

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS). June 1, 2021

Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis. May 31, 2021

Page 10 of 406